19 May 2022
Amolyt Pharma has announced its accepted abstracts that will be presented at the European Congress of Endocrinology (ECE 2022) and the Endocrine Society Meeting (ENDO 2022). The selection covers new data on treatments for rare endocrine diseases, including acromegaly and parathyroid disorders.
Largest study yet shows effective protection from COVID-19 vaccinations regardless of body mass index (BMI)
01 Jul 2022
Increased risk of stroke for women suffering fertility problems
01 Jul 2022
Link between obesity and size of testes may impact fertility
01 Jul 2022
Impressive impact factors announced for Society's journals!
28 Jun 2022
Policy engagement workshop for early career researchers
28 Jun 2022
